Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9301199 | 0.85 | KMT2A (0.41) | ALDH1A1MAPTLMNAKMT2AMEN1 | |
| SCHEMBL17289013 | 0.85 | SMN1; SMN2 (0.43) | ALDH1A1MAPTLMNAKMT2AMEN1 | |
| SCHEMBL9714149 | 0.84 | POLB (0.45) | ALDH1A1MAPTLMNATSHRKMT2A | |
| SCHEMBL28414250 | 0.75 | LMNA (0.48) | ALDH1A1LMNATSHRKMT2AMEN1 | |
| SCHEMBL16868436 | 0.73 | NPSR1 (0.53) | ALDH1A1MAPTLMNAKMT2AMEN1 | |
| SCHEMBL779323 | 0.71 | ALDH1A1 (0.51) | ALDH1A1MAPTLMNAKMT2AMEN1 | |
| SCHEMBL779782 | 0.71 | ALDH1A1 (0.59) | ALDH1A1MAPTLMNAKMT2AMEN1 | |
| SCHEMBL16868509 | 0.71 | LMNA (0.54) | ALDH1A1MAPTLMNATSHRKMT2A | |
| SCHEMBL914541 | 0.69 | PPARD (0.44) | ALDH1A1MAPTLMNATSHRKMT2A | |
| SCHEMBL14105717 | 0.69 | ALDH1A1 (0.49) | ALDH1A1MAPTLMNAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110903318-B | Preparation method of alkenyl phosphonate compound | 西北民族大学 | 2023-02-28 | — | — | CN | disclosed |
| CN-110903318-A | Preparation method of alkenyl phosphonate compound | 西北民族大学 | 2020-03-24 | — | — | CN | disclosed |
| US-9493494-B2 | Phosphinine oxide derivative and preparation method thereof | KNU-INDUSTRY COOPERATION FOUNDATION (KR) | 2016-11-15 | — | — | US | disclosed |
| US-20150344506-A1 | NOVEL PHOSPHININE OXIDE DERIVATIVE AND PREPARATION METHOD THEREOF | KNU-INDUSTRY COOPERATION FOUNDATION (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344506-A1 | NOVEL PHOSPHININE OXIDE DERIVATIVE AND PREPARATION METHOD THEREOF | PHOSPHO1, PPIP5K2, ITPA | ALDH1A1 3382/4885MAPT 4780/4885LMNA 4841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.